EGRNY yields 34147.73% · MRK yields 2.76%● Live data
📍 EGRNY pulled ahead of the other in Year 1
Combined, EGRNY + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of EGRNY + MRK for your $10,000?
China Evergrande Group, an investment holding company, primarily engages in the property development business in the People's Republic of China. It operates through four segments: Property Development, Property Investment, Property Management Services, and Other Businesses. It is involved in the development of residential properties, as well as other businesses, including property investment, property management, property construction, new energy vehicle, hotel operation, finance, internet, cultural tourism, and health businesses. The company was formerly known as Evergrande Real Estate Group Limited and changed its name to China Evergrande Group in July 2016. China Evergrande Group was incorporated in 2006 and is headquartered in Shenzhen, the People's Republic of China. China Evergrande Group operates as a subsidiary of Xin Xin (BVI) Limited.
Full EGRNY Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.